Plasma triglyceride and HDL-cholesterol concentrations in Vietnamese girls are affected by lipoprotein lipase, but not apolipoprotein CIII polymorphism

Journal of Nutrition

Volumn 136, Issue 6, 2006, Pages 1488-1492

  Nghiem, Nguyet Thu ^a   Mai, Ta Thi Tuyet ^b   Ohmori, Reiko ^c   Kuroki, Masatoshi ^d   Nguyen, Van Chuyen ^e   Hung, Nguyen Thi Kim ^b   Kawakami, Masanobu ^d   Kondo, Kazuo ^a  

^a OCHANOMIZU UNIVERSITY   (Japan)

^b Nutrition Center   (Viet Nam)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e JAPAN WOMEN'S UNIVERSITY   (Japan)

Author keywords

Apolipoprotein CIII Sstl; HDL cholesterol; Lipoprotein lipase S447X; Triglyceride; Vietnamese

Indexed keywords

APOLIPOPROTEIN C3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ANTHROPOMETRY; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; ENZYME CHEMISTRY; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LOW FAT DIET; PROTEIN POLYMORPHISM; RACE DIFFERENCE; RURAL AREA; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; URBAN AREA; VIET NAM;

EID: 33646759972     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/136.6.1488     Document Type: Article

References (37)

1. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81:7B-12B.
2. Assmann G, Schulte H, Funke H, von Eckardstein A. The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur Heart J. 1998;19:M8-14.
3. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106:3143-421.
4. Miller GJ, Miller NE. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet. 1975;1:16-9.
5. Gordon DJ, Rifkind BM. High-density lipoprotein - the clinical implications of recent studies. N Engl J Med. 1989;321:1311-6.
6. Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham heart study. Arteriosclerosis. 1988;8:737-41.
7. Oka K, Tkalcevic GT, Nakano T, Tucker H, Ishimura-Oka K, Brown WV. Structure and polymorphic map of human lipoprotein lipase gene. Biochim Biophys Acta. 1990;24:21-6.
8. Miesenbock G, Holzl B, Foger B, Brandstatter E, Paulweber B, Sandhofer F, Patsch JR. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest. 1993;91:448-55.
9. Hokanson JE. Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies. Int J Clin Lab Res. 1997;27:24-34.
10. Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation. 1999;99:2901-7.
11. Krauss RM, Herbert PN, Levy RI, Fredrickson DS. Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins. Circ Res. 1973;33:403-11.
12. Windler E, Havel RJ. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. J Lipid Res. 1985;26:556-65.
13. Rees A, Shoulders CC, Stocks J, Galton DJ, Baralle FE. DNA polymorphism adjacent to human apoprotein A-1 gene: relation to hypertriglyceridaemia. Lancet. 1983;1:444-6.
14. Ordovas JM, Civeira F, Genest J, Jr., Craig S, Robbins AH, Meade T, Pocovi M, Frossard PM, Masharani U, et al. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis. 1991;87:75-86.
15. Hoffer MJ, Sijbrands EJ, De Man FH, Havekes LM, Smelt AH, Frants RR. Increased risk for endogenous hypertriglyceridaemia is associated with an apolipoprotein C3 haplotype specified by the SstI polymorphism. Eur J Clin Invest. 1998;28:807-12.
16. Shoulders CC, Grantham TT, North JD, Gaspardone A, Tomai F, de Fazio A, Versaci F, Gioffre PA, Cox NJ. Hypertriglyceridemia and the apolipoprotein CIII gene locus: lack of association with the variant insulin response element in Italian school children. Hum Genet. 1996;98:557-66.
17. Kee F, Amouyel P, Fumeron F, Arveiler D, Cambou JP, Evans A, Cambien F, Fruchart JC, Ducimetiere P, et al. Lack of association between genetic variations of apo A-I-C-III-A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study. Atherosclerosis. 1999;145:187-95.
18. Khoi HH. Nhung van de dinh duong trong thoi ky chuyen tiep o Viet nam [Problems of nutrition in the transition period in Vietnam]. Hanoi, Vietnam: Nha xuat ban Y hoc [Medical Publisher]; 1996.
19. Khai PG. Cardiovascular diseases in the recent decade in Vietnam: diagnosis, treatment and prevention. In: Ha HK, Nguyen VC, Kawakami M, Do TKL, Nguyen XN, editors. Actual nutrition problems of Vietnam and Japan. Hanoi, Vietnam: Nha xuat ban Y hoc [Medical Publisher]; 1998: p. 72-5.
20. World Health Organization. Physical status: The use and interpretation of anthropometry. Geneva, 1995.
21. Yoshimura Y, Hanh TTM. Vietnamese Eiyokun software. HoChiMinh, Vietnam: Nha xuat ban Y hoc [Medical Publisher]; 2004.
22. Ministry of Health in Vietnam, National Institute of Nutrition. Nutritive composition table of Vietnamese foods. Hanoi, Vietnam: Nha xuat ban Y hoc [Medical Publisher]; 2000.
23. Ministry of Health in Vietnam, National Institute of Nutrition. Bang khuyen nghi nhu cau dinh duong cho nguoi Vietnam [Vietnamese recommended dietary allowances]. Hanoi, Vietnam: Nha xuat ban Y hoc [Medical Publisher]; 1997.
24. Lyamichev V, Mast AL, Hall JG, Prudent JR, Kaiser MW, Takova T, Kwiatkowski RW, Sander TJ, de Arruda M, et al. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat Biotechnol. 1999;17:292-6.
25. Nagano M, Yamashita S, Hirano K, Ito M, Maruyama T, Ishihara M, Sagehashi Y, Oka T, Kujiraoka T, et al. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay. J Lipid Res. 2002;43:1011-8.
26. Hardy GH. Mendelian proportions in a mixed population. Science. July 10, 1908;28:49-50.
27. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, et al. Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000. J Atheroscler Thromb. 2005;12:240-50.
28. McGladdery SH, Pimstone SN, Clee SM, Bowden JF, Hayden MR, Frohlich JJ. Common mutations in the lipoprotein lipase gene (LPL): effects on HDL-cholesterol levels in a Chinese Canadian population. Atherosclerosis. 2001;156:401-7.
29. Corella D, Guillen M, Saiz C, Portoles O, Sabater A, Folch J, Ordovas JM. Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: interaction with tobacco smoking and the APOE locus. J Lipid Res. 2002;43:416-27.
30. Humphries SE, Nicaud V, Margalef J, Tiret L, Talmud PJ. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European atherosclerosis research study (EARS). Arterioscler Thromb Vasc Biol. 1998;18:526-34.
31. Chen W, Srinivasan SR, Elkasabany A, Ellsworth DL, Boerwinkle E, Berenson GS. Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa heart study. Atherosclerosis. 2001;159:367-73.
32. Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science. 1990;249:790-3.
33. Ko YL, Ko YS, Wu SM, Teng MS, Chen FR, Hsu TS, Chiang CW, Lee YS. Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese. Hum Genet. 1997;100:327-33.
34. Song J, Park JW, Park H, Kim JQ. Linkage disequilibrium of apoAI-CIII-AIV gene cluster and their relationship to plasma triglyceride, apoAI and CIII levels in Koreans. Mol Cells. 1998;8:12-8.
35. Russo GT, Meigs JB, Cupples LA, Demissie S, Otvos JD, Wilson PW, Lahoz C, Cucinotta D, Couture P, et al. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis. 2001;158:173-81.
36. Ordovas JM, Schaefer EJ. Genes, variation of cholesterol and fat intake and serum lipids. Curr Opin Lipidol. 1999;10:15-22.
37. Olivieri O, Stranieri C, Bassi A, Zaia B, Girelli D, Pizzolo F, Trabetti E, Cheng S, Grow MA, et al. ApoCIII gene polymorphisms and risk o coronary artery disease. J Lipid Res. 2002;43:1450-7.